Cite
Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy.
MLA
Li, Wentao, et al. “Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy.” Immunity (10747613), vol. 53, no. 2, Aug. 2020, p. 456. EBSCOhost, https://doi.org/10.1016/j.immuni.2020.07.011.
APA
Li, W., Qiu, S., Chen, J., Jiang, S., Chen, W., Jiang, J., Wang, F., Si, W., Shu, Y., Wei, P., Fan, G., Tian, R., Wu, H., Xu, C., & Wang, H. (2020). Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy. Immunity (10747613), 53(2), 456. https://doi.org/10.1016/j.immuni.2020.07.011
Chicago
Li, Wentao, Shizhen Qiu, Jian Chen, Shutan Jiang, Wendong Chen, Jingwei Jiang, Fei Wang, et al. 2020. “Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy.” Immunity (10747613) 53 (2): 456. doi:10.1016/j.immuni.2020.07.011.